Humacyte, Inc.
Develops and manufactures universally implantable, bioengineered human acellular tissues.
HUMA | US
Overview
Corporate Details
- ISIN(s):
- US0207512023 (+3 more)
- LEI:
- Country:
- United States of America
- Address:
- 2525 EAST NORTH CAROLINA HIGHWAY 54, 27713 DURHAM
- Website:
- https://humacyte.com/
- Sector:
- Manufacturing
Description
Humacyte, Inc. is a regenerative medicine company that develops and manufactures universally implantable, bioengineered human tissues. The company utilizes a proprietary platform to produce acellular tissues that are designed to be available "off-the-shelf." Upon implantation, these tissues are repopulated by the patient's own cells, remodeling over time to become living tissue. Its first U.S. FDA-approved product, SYMVESS™, is a human acellular vessel (HAV) developed for arterial replacement and repair, particularly in cases of vascular trauma. Humacyte is leveraging its foundational technology to build a pipeline of product candidates for a broad range of diseases, injuries, and chronic conditions.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all Humacyte, Inc. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Humacyte, Inc.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Humacyte, Inc. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
